Wells Fargo Maintains Equal-Weight on Bristol-Myers Squibb, Raises Price Target to $65
بريستول مايرز سكويب كو
Bristol-Myers Squibb Company BMY | 0.00 |
Wells Fargo analyst Mohit Bansal maintains Bristol-Myers Squibb (NYSE:
BMY) with a Equal-Weight and raises the price target from $60 to $65.